Germ Line Polymorphism in Metastatic Progression
Open Access
- 1 February 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (3) , 1251-1254
- https://doi.org/10.1158/0008-5472.can-05-3705
Abstract
Somatic genetic analysis of tumors and metastases has yielded a plethora of information regarding genes associated with cancer progression. However, somatic alterations in tumor cells are only one source of variability. Genetic polymorphism may also play a significant role in person-to-person variability in metastasis frequency, raising the intriguing possibility that some individuals could be predisposed to secondary tumor development. The identification and characterization of these polymorphisms may have significant implications for the development of tailored treatment or prevention of recurrent disease. (Cancer Res 2006; 66(3): 1251-4)Keywords
This publication has 11 references indexed in Scilit:
- Breast cancer metastasis: markers and modelsNature Reviews Cancer, 2005
- Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasisClinical & Experimental Metastasis, 2005
- Multiple-laboratory comparison of microarray platformsNature Methods, 2005
- The Mouse Genome Database (MGD): from genes to mice--a community resource for mouse biologyNucleic Acids Research, 2004
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 ratsKidney International, 1999
- Genetic control of pathogenesis of diabetes in C3H mice. Influence of the major histocompatibility complexDiabetes, 1984